The Role and Function of Clinical Research Nurses in Anti-tumor Drug Clinical Trials for Lung Cancer Patients.
10.3779/j.issn.1009-3419.2022.102.30
- Author:
Fujie HAO
1
;
Qin ZHU
2
;
Sue WANG
2
;
Ya LIU
2
;
Lin JIANG
2
;
Ruili PAN
2
Author Information
1. School of Nursing, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100144, China.
2. Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital,
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100010, China.
- Publication Type:Journal Article
- Keywords:
Clinical research nurse;
Drug clinical trials;
Lung neoplasms;
Role and function
- MeSH:
Antineoplastic Agents/therapeutic use*;
Humans;
Lung Neoplasms/drug therapy*
- From:
Chinese Journal of Lung Cancer
2022;25(7):501-505
- CountryChina
- Language:Chinese
-
Abstract:
Clinical trials of anti-tumor drugs is not only the important way to develop new drugs, but also the most advanced treatment methods for malignant tumors, bringing survival benefits to patients. There are a large number of new anti-tumor drug clinical trials for lung cancer patients, covering a wide variety of anti-tumor drugs, and with rapid progress and high efficiency of clinical transformation. These trials could not be carried out successfully without the joint efforts of the research team, in which the research nurses also played a role that should not be underestimated. Combined with the work content of clinical research nurses, this paper introduced the post management, role function, core competence and career development prospect of clinical research nurses in the process of carrying out clinical trial of lung cancer drugs in detail. In order to provide reference for more medical institutions to carry out related work, and promote the further development of clinical research nurses to standardization and specialization.
.
